Naltrexone Treatment Centers in Colorado

Yes. MAT with methadone or buprenorphine is the recommended standard of care in pregnancy — ACOG and SAMHSA both endorse it. Colorado providers coordinate with obstetrics to monitor mother and baby throughout pregnancy and the neonatal period.

Vivitrol monthly cost without insurance typically falls between $1,100 and $1,500 per injection in Colorado. The manufacturer Alkermes offers a patient-assistance co-pay savings card; state-funded programs also cover Vivitrol for uninsured patients in many counties.

Yes. Pregnancy-related Health First Colorado coverage includes MAT with no copays and priority access to Colorado perinatal-MAT programs. Many Health First Colorado plans also extend coverage for 12 months postpartum to protect the mother–infant dyad.

Yes. Blue Cross Blue Shield plans in Colorado cover all three FDA-approved MAT medications. BCBS typically requires the provider to be in-network; most major naltrexone providers in Denver and across Colorado accept BCBS.

For methadone, SAMHSA’s 2024 final rule allows OTPs in Colorado to grant up to 28 days of take-home doses once clinical-stability criteria are met. For buprenorphine, 30-day prescriptions are standard and 90-day fills are permitted in many Colorado plans. Long-acting naltrexone is a single monthly injection, so no take-home supply applies.

No. There is no legal or clinical cap on how long you can remain on naltrexone in Colorado. Insurance must continue to cover MAT as long as the prescribing clinician documents medical necessity.

For methadone and buprenorphine, continued opioid use at entry is expected — the medication is designed to stop use safely. For naltrexone, 7–14 opioid-free days are required first. Your Colorado clinician will confirm the correct induction strategy at intake.

A positive urine drug screen is expected for most patients entering MAT — it confirms the diagnosis. Positive screens are not used to deny admission at any Colorado SAMHSA-certified OTP. Your clinician interprets results and builds an individualized plan from there.

Long-term opioid-agonist therapy (methadone, buprenorphine) can lower testosterone in some men and affect menstruation in some women. Annual hormone panels are reasonable. Switching medications or adjusting dose resolves most cases; endocrinology referral is available in Colorado for persistent issues.

Yes. Most Colorado regions have perinatal-addiction programs coordinating OB care, MAT, and social support. Call 988 or SAMHSA 1-800-662-4357 for Colorado-specific referral. Denver-area hospitals typically have dedicated perinatal-addiction coordinators.

Peer-recovery support workers are trained individuals with lived recovery experience who provide mentoring, accompaniment to appointments, and navigation of resources. Colorado Medicaid reimburses peer-support services; most mid-sized naltrexone providers employ certified peer specialists.

Life-insurance applications typically ask about current medications and substance-use history. Failing to disclose can void a policy. Some insurers rate MAT neutrally for stable long-term patients; shop among carriers and consider no-medical-exam policies if rates are unfavorable.